Biotech: Pressemitteilungen - Kategorie - Seite 61

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Hemostemix Executes Strategic Alliance with Hemostemix Asia for Expansion of Phase-2 Clinical Trial to Taiwan

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/14/15 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM), a clinical-stage autologous cell-therapy company, announced to ...

M Pharmaceutical's CEO Issues Letter to Shareholders

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/10/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...

Theravance Biopharma Presents Positive Clinical Data on Fixed-Dose Combination (FDC) of Axelopran (TD-1211) and Oxycodone at PAINWeek(R) 2015

DUBLIN, IRELAND: FDC Designed to Offer Pain Relief Without Opioid-Induced Constipation (OIC); Study Results Demonstrate Bioequivalence of Oxycodone From FDC Compared to Individual Components With No Significant Impact ...

Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies

LONDON, ONTARIO: UHN (University Health Network) agreement transitions Sernova to an integrated therapeutic cell regenerative medicine Company ...

iBio Fibrosis Therapeutics Program Receives NIH Grant Support

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 09/09/15 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, announced the award of a g ...

Flamel Technologies Announces FDA Acceptance of Third NDA Filing

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/09/15 -- Flamel Technologies (NASDAQ: FLML) today announced that it has received a Prescription Drug User Fee Act (PDUFA) date of April 30, 2016 from the U.S. Food ...

Calyx's Subsidiary Cannigistics Announces Platform Licensing Agreement

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/09/15 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or "the Company") is pleased to announce that its wholly-owned sub ...

Sun BioPharma Adopts OTCPink Symbol SNBP

MINNEAPOLIS, MN: Company's Clinical Development Program Focuses on Novel Approach to Treatment of Pancreatic Cancer ...

BioCentury Co-Founder Steps Down as Editor-in-Chief

REDWOOD CITY, CA: Dr. Karen Bernstein to Focus on Chairman's Role; "Editorial Team in Great Hands" as BioCentury Publishes Industry-Shaping 'Back to School' Essay for 23rd Year ...

MedMira Closes Investment from OnSite Lab

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/08/15 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR) has closed the CAD $5 million equity investment with OnSite Lab Holding AG (OnSite Lab) announced Septem ...

Theravance Biopharma to Present New Data Highlighting in vitro Potency of VIBATIV(R) (telavancin) Against Gram-Positive Bacteria, Including MRSA, at 2015 ICAAC

DUBLIN, IRELAND: Presentations Provide Further Confirmation of in vitro Potency Advantage of VIBATIV Against Isolates From Difficult-to-Treat Infections as Compared to Vancomycin, Daptomycin and Linezolid ...

Atossa Genetics Receives Approval to Begin Clinical Study in Israel

SEATTLE, WA: Study to Evaluate Company's ForeCYTE Breast Aspirator Device Will Submit a Subset of Specimens From Carriers of the BRCA Germline Mutation to Contemporary Molecular Tests in Addition to Cytology; ...

Threshold Pharmaceuticals Appoints Mark Hopkins, J.D., Ph.D., Vice President of Intellectual Property and Assistant General Counsel

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/08/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced the appointment of Mark Hopkins, J.D., Ph.D., as Vice President of Intellectual ...

Atossa Genetics Inc. to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 09/04/15 -- (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast health conditions and th ...

Titan Pharmaceuticals to Present at Rodman & Renshaw 17th Annual Global Investment Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/03/15 -- (OTCQB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing i ...

Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 09/03/15 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:David Hung, M.D., president and chief executive offi ...

M Pharmaceutical to Present at SeeThruEquity Conference in New York

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/03/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...


Seite 62 von 255:  « ..  61 62 63  64  65  66  67  68  69  70  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z